Skip to main content
. 2019 Aug 16;35(5):697–708. doi: 10.1002/joa3.12226

Table 2.

Comorbidities

  Overall
(n = 2113)
Warfarin
(n = 725)
DOAC
(n = 1118)
P value
Stroke/TIA 196 (9.3%) 82 (11%) 106 (10%) .208
Heart failure 463 (22%) 244 (34%) 193 (17%) <.001
EF < 35% 110 (5.2%) 73 (10%) 34 (3%) <.001
Valvular disease 284 (13%) 180 (25%) 86 (8%) <.001
Aortic regurgitation 77 (3.6%) 44 (6%) 25 (2%) <.001
Mitral regurgitation 173 (8.2%) 106 (15%) 57 (5%) <.001
Tricuspid regurgitation 63 (3.0%) 47 (6%) 12 (1%) <.001
Aortic stenosis 40 (1.9%) 27 (4%) 7 (0.6%) <.001
Mitral stenosis 28 (1.3%) 26 (4%) 2 (0.2%) <.001
Ischemic heart disease 153 (7.2%) 75 (10%) 66 (6%) .001
Cardiomyopathy 178 (8.4%) 84 (12%) 83 (7%) .003
Vascular disease 130 (6.2%) 53 (7%) 66 (6%) .245
Diabetes mellitus 328 (16%) 133 (18%) 163 (15%) .032
Hypertension 1,208 (57%) 423 (58%) 663 (59%) .698
Renal disease 242 (11%) 137 (19%) 77 (7%) <.001
Hemodialysis 11 (0.5%) 4 (0.6%) 0 (0%) .024
Liver disease 31 (1.5%) 6 (0.8%) 22 (2%) .053
Dementia 56 (2.7%) 28 (4%) 22 (2%) .009
History of open‐heart surgery 211 (10%) 133 (18%) 64 (6%) <.001
History of CABG 35 (1.7%) 23 (3%) 9 (0.8%) <.001
History of PCI 116 (5.5%) 55 (8%) 54 (5%) .015
History of CA for AF 614 (29%) 163 (22%) 277 (25%) .264
Pacemaker implantation 114 (5.4%) 66 (0.8%) 40 (4%) <.001
CHADS2 score 1.5 ± 1.1 1.8 ± 1.2 1.4 ± 1.1 <.001
CHA2DS2‐VASc score 2.6 ± 1.6 3.0 ± 1.6 2.5 ± 1.5 <.001
HAS‐BLED score 1.3 ± 1.0 1.6 ± 1.0 1.2 ± 0.9 <.001

Values are presented as the n (%). Vascular disease indicates patients with a prior myocardial infarction, peripheral arterial disease, or aortic plaque. Renal disease indicates the patients with hemodialysis, transplantations, or abnormalities of the creatinine level of >2.26 mg/dL or >200 μmol/L. Liver disease indicates patients with cirrhosis or a bilirubin level > 2×normal with an AST/ALT/AP >3 × normal.

Abbreviations: AF, atrial fibrillation; CABG, coronary arterial bypass grafting; EF, ejection fraction; TIA, transient ischemic attack; PCI, percutaneous coronary intervention.